Makomo
Active member
An fMRI , might they be able to pinpoint six different types of depression and tell whether a given treatment will be more or less effective for three of these categories. This is post marketing drug monitoring reported in a study conducted by Stanford Medicine in California and published in the journal Nature Medicine today.
The participants were 801 patients who have had a prior diagnosed depression or an anxiety disorder. The researchers used fMRI in the actual state of rest and during the task that gives data with the help of cognition and emotional processes. The researchers were interested in the connections between different structures in the brain and consolidated the images to regard six kinds of patterns of activity. Further, 250 subjects were randomly selected and grouped to be administered one of the three most prescribed drugs in the country for the treatment of depression or behavior activist talk session.
The participants were 801 patients who have had a prior diagnosed depression or an anxiety disorder. The researchers used fMRI in the actual state of rest and during the task that gives data with the help of cognition and emotional processes. The researchers were interested in the connections between different structures in the brain and consolidated the images to regard six kinds of patterns of activity. Further, 250 subjects were randomly selected and grouped to be administered one of the three most prescribed drugs in the country for the treatment of depression or behavior activist talk session.
: Tailoring therapies to specific subtypes can increase effectiveness.
: Understanding the subtype can lead to more accurate assessments.
: Medications can be chosen based on subtype characteristics.
: Psychotherapies can be more precisely applied.
: Patients can develop skills suited to their subtype.
: Recognizing specific symptoms can lead to quicker treatment.
